Lawmakers strike deal on ‘practically clean’ FDA user fee bill

“Sen. Murray has reached a deal on a practically clean reauthorization that ensures congressional inaction won’t force FDA to send out pink slips along with some additional policies,” the aide said. “But even after we have addressed this immediate challenge before the looming deadline, she believes we can’t, and she won’t, stop pushing for the kind of reforms families need to see from the drug industry and this critical agency.”

Still, Murray cautioned Thursday, “we have a lot more work to do. He’s left us a lot of work to do.”

In the House, Energy and Commerce Committee Chairman Frank Pallone Jr., DN.J., would not confirm whether House lawmakers had signed onto the deal.

Congressional leaders are still haggling over the stopgap spending bill that will serve as a vehicle for the user fee package. Republican leadership has been angling for a clean reauthorization in addition to a clean spending bill.

The text is expected to eschew most of the varied policy riders that passed out of the Energy and Commerce and HELP committees. Those include overhauls of the diagnostic, dietary and cosmetic industries as well as provisions on medical device cybersecurity, diversity in clinical trials, regulation of infant formula and oversight of FDA accelerated drug approvals.

Leave a Reply

Your email address will not be published.

Back to top button